You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MYC Amplification

Showing 1 - 25 of 500
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Poland, United

Recruiting
  • Relapsed Non Hodgkin Lymphoma
  • +6 more
  • Cincinnati, Ohio
  • +4 more
Aug 3, 2022

Ewing Sarcoma, Myxoid/Round Cell Liposarcoma, Synovial Sarcoma Trial in United States (PRT2527)

Recruiting
  • Ewing Sarcoma
  • +7 more
  • Denver, Colorado
  • +5 more
Jun 9, 2022

Phase 1, NSCLC, SCLC Trial in United States (Oral MRT-2359)

Recruiting
  • NSCLC
  • +6 more
  • Oral MRT-2359
  • Scottsdale, Arizona
  • +7 more
Dec 20, 2022

CNS Tumor, Solid Tumor Trial in Worldwide (Nivolumab and Entinostat)

Recruiting
  • CNS Tumor
  • Solid Tumor
  • Nivolumab and Entinostat
  • Randwick, New South Wales, Australia
  • +13 more
Nov 8, 2022

Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable Trial in San Antonio (OTX-2002, Tyrosine kinase

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • San Antonio, Texas
    Next Oncology
Aug 9, 2022

Advanced Cancers Trial in Boston (LY2606368)

Active, not recruiting
Has Results
  • Advanced Cancers
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 18, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

Leukemia, Myelodysplastic Syndrome(MDS) Trial in Duarte, Houston (fadraciclib)

Recruiting
  • Leukemia
  • Myelodysplastic Syndrome(MDS)
  • Duarte, California
  • +1 more
Apr 1, 2022

SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

Recruiting
  • SCLC
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Tumors Trial in Chile, United States (VIP152 (BAY 1251152), VIP152 (BAY 1251152) 30 mg, Keytruda)

Recruiting
  • Neoplasms
  • VIP152 (BAY 1251152)
  • +3 more
  • Springdale, Arkansas
  • +12 more
Mar 24, 2022

Adenosquamous Carcinoma of the Pancreas Trial run by the NCI (Minnelide)

Recruiting
  • Adenosquamous Carcinoma of the Pancreas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 7, 2022

Next Generation " Pre-clinical Model for Colorectal Cancer

Recruiting
  • Colorectal Cancer Metastases and Hepatocellular Carcinomas
  • Tumor /metastases removal
  • Marseille, France
    ap-HM hopital nord
May 17, 2022

Breast Cancer Liquid Biopsy Stratification

Active, not recruiting
  • Breast Cancer
  • Nucleosome positioning
  • Graz, Austria
    Medical University of Graz
Mar 22, 2021

Lung Cancer, Mesothelioma Trial in Houston (Alisertib)

Completed
Has Results
  • Lung Cancer
  • Mesothelioma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 23, 2022

Solid Tumor, Adult, Lymphoma Trial in Korea, Republic of, Spain, United States (Fadraciclib)

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • Duarte, California
  • +3 more
Apr 1, 2022

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Small Cell Lung Cancer Trial in Seoul (AZD1775)

Terminated
  • Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Keunchil Park
Sep 18, 2018

Speech Perception and Amplification Benefit During Infancy

Not yet recruiting
  • Hearing Loss
  • +3 more
  • Hearing Aids
  • Aurora, Colorado
    University of Colorado School of Medicine - Speech Perception Ov
Dec 14, 2022

Personal Sound Amplification Device

Completed
Has Results
  • Hearing Loss
  • Ascending Hearing Technologies device
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Jan 20, 2023

NSCLC Metastatic Trial in Seoul (Lazertinib, Tepotinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Seoul, Gangnam-gu, Korea, Republic of
    Samsung Medical Center
Oct 27, 2023

Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL) Trial in United Kingdom (SRA737)

Completed
Has Results
  • Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
  • Sutton, London, United Kingdom
  • +14 more
Mar 9, 2022

stratification of High-risk Intestinal Metaplasia (GCEP2 Study)

Recruiting
  • Stomach Neoplasm
  • Blood Collection, processing and analyses
  • +2 more
  • Stanford, California
  • +7 more
Mar 13, 2023

DLBCL Trial in Qingdao (Selinexor combined with Prednisone, Etoposide, and Lenalidomide)

Not yet recruiting
  • DLBCL
  • Selinexor combined with Prednisone, Etoposide, and Lenalidomide
  • Qingdao, Shandong, China
    the affiliated hospital of Qingdao University
Aug 18, 2022

Stomach Cancer, Adenocarcinoma Trial in Seoul (Durvalumab, Savolitinib)

Recruiting
  • Stomach Cancer, Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 10, 2023

Refractory Solid Tumors Trial in Seoul (pazopanib)

Completed
  • Refractory Solid Tumors
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022